Placental development in normal and compromised pregnancies - A review

Placenta

Volumn 23, Issue SUPPL. 1, 2002, Pages

  Regnault, T R H ^a   Galan, H L ^a   Parker, T A ^a   Anthony, R V ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; PROTEIN DERIVATIVE; VASCULOTROPIN; GROWTH FACTOR RECEPTOR;

CELL ADHESION; CELL DIFFERENTIATION; CELL INTERACTION; CHRONOLOGY; CORRELATION ANALYSIS; DEVELOPMENTAL STAGE; ENVIRONMENTAL FACTOR; GENE CONTROL; GENE SWITCHING; HUMAN; INTRAUTERINE GROWTH RETARDATION; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NONHUMAN; PLACENTA CIRCULATION; PLACENTA DEVELOPMENT; PREECLAMPSIA; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SHEEP; STATISTICAL SIGNIFICANCE; ADULT; ANGIOGENESIS; ANIMAL; DISEASE MODEL; FEMALE; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROCIRCULATION; MORPHOGENESIS; PATHOPHYSIOLOGY; PHYSIOLOGY; PLACENTA; PLACENTA INSUFFICIENCY; PREGNANCY; PRENATAL DEVELOPMENT; TROPHOBLAST; ULTRASTRUCTURE; VASCULARIZATION;

ADULT; ANGIOGENESIS INDUCING AGENTS; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FETAL GROWTH RETARDATION; HUMANS; MICROCIRCULATION; MORPHOGENESIS; NEOVASCULARIZATION, PHYSIOLOGIC; PLACENTA; PLACENTAL INSUFFICIENCY; PREGNANCY; RECEPTORS, GROWTH FACTOR; SHEEP; TROPHOBLASTS;

EID: 0012746562     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.2002.0792     Document Type: Article

References (95)

1. Ahmed AS, Li XF, Dunk CE, Whittle MJ & Rollason T (1995) Colocalisation of vascular endothelial growth factor and its flt-1 receptor in human placenta. Growth Factors, 12, 235-243.
2. Alexander G & Williams D (1971) Heat stress and development of the conceptus in domestic sheep. J Agric Sci, 76, 53-72.
3. Anderson AH, Fennessey PV, Meschia G, Wilkening RB & Battaglia FC (1997) Placental transport of threonine and its utilization in the normal and growth-restricted fetus. Am J Physiol, 272, E892-E900.
4. Barker DJP, Bull AR, Osmond C & Simmonds SJ (1990) Fetal and placental size and risk of hypertension in adult life. Brit Med J, 301, 259-262.
5. Barker DJP, Gluckman PD, Godfrey KM, Harding JE, Owens JA & Robinson JS (1993a) Fetal nutrition and cardiovascular disease in adult life. Lancet, 341, 938-941.
6. Barker DJP, Hales CN, Fall CHD, Osnond C, Phipps K & Clark PMS (1993b) Type 2 diabetes mellitus, hypertension and hyperlipidaemia: relation to reduced fetal growth. Diabetologia, 36, 62-67.
7. Barker D, Osmond C, Golding J, Kuth D & Wadsworth M (1989) Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. Brit Med J, 298, 564-567.
8. Bell AW, McBride BW, Slepetis R, Early RJ & Currie WB (1989) Chronic heat stress and perinatal development in sheep: I. Conceptus and maternal plasma hormones and metabolites. J Anim Sci, 67, 3289-3299.
9. Bell AW, Wilkening RB & Meschia G (1987) Some aspects of placental function in chronically heat-stressed ewes. J Dev Physiol, 9, 17-29.
10. Boshier DP (1969) A histological and histochemical examination of implantation and early placentome formation in sheep. J Reprod Fertil, 19, 51-61.
11. Boyd JD & Hamilton WJ (1952) Cleavage, early development and implantation of the egg. In Marshall's Physiology of Reproduction (Ed.) Parkes AS, pp. 1-110. London: Longman, Green.
12. Brar HS & Rutherford SE (1988) Classification of intrauterine growth retardation. Sem Perinatol, 12, 2-10.
13. Brosens I, Robertson WB & Dixon HG (1967) The physiological response to the vessels of the placental bed to normal pregnancy. J Pathol Bacteriol, 93, 569-579.
14. 3. J Clin Invest, 105, 577-587.
15. Caniggia I, Winter J, Lye SJ & Post M (2000b) Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia. Placenta, 14, S25-30.
16. Cao Y, Chen H, Zhou L, Chiang MK, Anand-Apte B, Weatherbee JA, Wang Y, Fang F, Flanagan JG & Tsang ML (1996) Heterodimers of placenta growth factor/vascular growth factor, endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR. J Biol Chem, 271, 3154-3162.
17. Charnock-Jones DS, Sharkey AM, Boocock CA, Ahmed A, Plevin R, Ferrara N & Smith SK (1994) Localization and activation of the receptor for vascular endothelial growth factor on human trophoblast and choriocarcinoma cells. Biol Reprod, 51, 524-530.
18. Cooper JC, Sharkey AM, Charnock-Jones DS, Palmer CR & Smith SK (1996) VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia. Br J Obstet Gynaeco, 103, 1191-1196.
19. Crescimanno C, Marzioni D, Persico MG, Vuckovic M, Muhauser J & Castelucci M (1995) Expression of bFGF, PlGF and their receptors in the human placenta. Placenta, 16, A13.
20. DiSalvo J, Bayne ML, Conn G, Kwok PW, Trivedi PG, Soderman DD, Palisi TM, Sullivan KA & Thomas KA (1995) Purification and characterization of a naturally occurring vascular endothelial growth factor-placenta growth factor heterodimer. J Biol Chem, 270, 7717-7723.
21. Dunk C & Ahmed A (2001) Expression of VEGF-G and activation of its receptors VEGFR-2 and VEGFR-3 in trophoblast. Histo Histopathol, 16, 359-375.
22. Dunk C, Shams M, Nijjar S, Rhaman M, Qiu Y, Bussolati B & Ahmed A (2000) Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. Am J Pathol, 156, 2185-2199.
23. Dvorak HF, Brown LF, Detmar M & Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Physiol, 146, 1029-1039.
24. Economides DL & Nicolaides KH (1989) Blood glucose and oxygen tension levels in small-for-gestational-age fetuses. Am J Obstet Gynecol, 160, 385-389.
25. Fuh G, Garcia C & de Vos AM (2000) The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor Flt-1. J Biol Chem, 275, 26690-26695.
26. Galan HL, Hussey MJ, Barbera A, Ferrazzi E, Chung M, Hobbins JC & Battaglia FC (1999) Relationship of fetal growth to duration of heat stress in an ovine model of placental insufficiency. Am J Obstet Gynecol, 180, 1278-1282.
27. Galan HG, Hussey MJ, Chung M, Chyu JK, Hobbins JC & Battaglia FC (1998) Doppler velocimetry of growth restricted fetuses in an ovine model of placental insufficiency. Am J Obstet Gynecol, 178, 451-456.
28. Galan HL, Regnault TRH, Le Cras TD, Tyson RW, Anthony RV, Wilkening RB & Abman SH (2001) Cotyledon and binucleate cell nitric oxide synthase expression in an ovine model of fetal growth retardation. J App Physiol, 90, 2420-2426.
29. Genbacev O, Krtolica A, Kaelin W & Fisher SJ (2001) Human cytotrophoblast expression of the von Hipple-Lindau protein is downregulated during uterine invasion in situ and upregulated by hypoxia in vitro. Dev Biol, 233, 526-536.
30. Giles WB, Trudinger BJ & Baird P (1985) Fetal umbilical artery flow velocity wafeforms and placental resistance, pathological correlation. Br J Obstet Gynaecol, 92, 31-38.
31. Glazier JD, Cetin I, Perugino G, Ronzoni S, Grey AM, Mahendran D, Marconi AM, Pardi G & Sibley CP (1997) Association between the activity of the system A amino acid transporter in the microvillous plasma membrane of the human placenta and severity of fetal compromise in intrauterine growth restriction. Ped Res, 42, 514-519.
32. Gluzman-Poltorak Z, Cohen T, Herzog Y & Neufeld G (2000) Neuropilin-2 and neuropilin-1 are receptors for the 165-amino acid form of vascular endothelial growth factor (VEGF) and of placenta growth factor-2, but only neuropilin-2 functions as a receptor for the 145-amino acid form of VEGF. J Biol Chem, 275, 18040-18045.
33. Goldman-Wohl DS, Ariel I, Greenfield C, Lavy Y & Yagel S (2000) Tie-2 and angiopoietin-2 expression at the fetal-maternal interface: a receptor ligand model for vascular remodeling. Mol Hum Reprod, 6, 81-87.
34. Jansson T, Scholtbach V& Powell TL (1998) Placental transport of leucine and lysine is reduced in intrauterine growth restriction. Ped Res, 44, 532-537.
35. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N & Alitalo K (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGF-2) receptor tyrosine kinases. EMBO J, 15, 290-298.
36. Kaufmann P (1982) Development and differentiation of the human villous tree. Biblio Anat, 22, 29-39.
37. Kaufmann P, Sen DK & Schweikhart G (1979) Classification of human placental villi. I. Histology. Cell Tissue Res, 200, 409-423.
38. Khaliq A, Dunk C, Jiang J, Shams M, Li XF, Acevedo C, Weich H, Whittle M & Ahmed A (1999) Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for 'placental hyperoxia' in intrauterine growth restriction. Lab Invest, 79, 151-170.
39. Kilby MD, Afford S, Li XF, Strain AJ, Ahmed A & Whittle MJ (1996) Localization of hepatocyte growth factor (HGF) and its receptor (c-met) protein and mRNA in human term placenta. Growth Factors, 13, 133-139.
40. Kingdom J, Huppertz B, Seaward G & Kaufmann P (2000) Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol, 92, 35-43.
41. Kingdom JC & Kaufmann P (1997) Oxygen and placental villous development: origins of fetal hypoxia. Placenta, 18, 613-621.
42. Kingdom JC & Kaufmann P (1999) Oxygen and placental vascular development. Adv Exp Med Biol, 474, 259-275.
43. Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U & Risau W (1998) Angiopoietin-l induces sprouting angiogenesis in vitro. Curr Biol, 8, 529-532.
44. Krebs C, Longo LD & Leiser R (1997) Term ovine placental vasculature: comparison of sea level and high altitude conditions by corrosion cast and histomorphometry. Placenta, 18, 43-51.
45. Krebs C, Macara LM, Leiser R, Bowman AW, Greer IA & Kingdom JCP (1996) Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. Am J Obstet Gynecol, 175, 1834-1842.
46. Kroll J & Waltenberger J (1998) VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commun, 252, 743-746.
47. Lee MML & Yeh M (1986) Fetal microcirculation of abnormal human placenta. I. Scanning electron microscopy of placental vascular casts from small for gestational age fetus. Am J Obstet Gynecol, 154, 1133-1139.
48. Leiser R, Krebs C, Ebert B & Dantzer V (1997) Placental corrosion cast studies: a comparison between ruminants and humans. Microsc Res Tech, 38, 76-87.
49. Levy NS, Chung S, Furneaux H & Levy AP (1998) Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J Biol Chem, 273, 6417-6423.
50. Lyall F, Greer IA, Young A & Myatt L (1996) Nitric oxide concentrations are increased in the feto-placental circulation in intrauterine growth restriction. Placenta, 17, 165-168.
51. Lyall F, Young A, Boswell F, Kingdom JC & Greer IA (1997) Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta, 18, 269-276.
52. Lyttle DJ, Fraser KM, Fleming SB, Mercer AA & Robinson AJ (1994) Homologs of a vascular endothelial growth factor are encoded by the poxvirus orf virus. J Virol, 68, 84-92.
53. Macara L, Kingdom JC, Kaufmann P, Kohnen G, Hair J, More IA, Lyall F & Greer IA (1996) Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical Doppler waveforms. Placenta, 17, 37-48.
54. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN & Yancopoulos GD (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science, 277, 55-60.
55. Marconi AM, Paolini CL, Stramare L, Cetin I, Fennessey PV, Pardi G & Battaglia FC (1999) Steady state maternal-fetal leucine enrichments in normal and intrauterine growth-restricted pregnancies. Ped Res, 46, 114-119.
56. Maxwell PH, Wiesener MS, Chang G-W, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER & Ratcliffe PJ (1999) The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature, 399, 271-275.
57. Meekins JW, Pijenborg R, Hanssens M, McFadyen IR & VanAsshe A (1994) A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol, 101, 669-674.
58. Mellor DJ & Murray L (1981) Effects of placental weight and maternal nutrition on the growth rates of individual fetuses in single and twin bearing ewes during late pregnancy. Res Vet Sci, 30, 198-204.
59. Mellor DJ & Murray L (1982) Effects on the rate of increase in fetal girth of refeeding ewes after short periods of sever undernutrition during late pregnancy. Res Vet Sci, 32, 377-382.
60. Migdal M, Huppertz B, Tessler S, Comforti A, Shibuya M, Reich R, Baumann H & Neufeld G (1998) Neuropilin-1 is a placenta growth factor-2 receptor. J Biol Chem, 273, 22272-22278.
61. Myatt L, Eis AL, Brockman DE, Greer IA & Lyall F (1997) Endothelial nitric oxide synthase in placental villous tissue from normal, pre-eclamptic and intrauterine growth restricted pregnancies. Hum Reprod, 12, 167-172.
62. Nieto-Diaz A, Villar J, Matorras-Weinig R & Valenzuela-Ruiz P (1996) Intrauterine growth retardation at term: association between anthropometric and endocrine parameters. Acta Obstet Gynecol Scand, 75, 127-131.
63. Norberg S, Powell TL & Jansson T (1998) Intrauterine growth restriction is associated with a reduced activity of placental taurine transporters. Ped Res, 44, 233-238.
64. Oh H, Takagi H, Suzuma K, Otani A, Matsumura M & Honda Y (1999) Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem, 274, 15732-15739.
65. Olofsson B, Pajusola K, Kaipainen A, von Euler G, Juokov V, Saksela O, Orpana A, Pettersson RF, Alitalo K & Eriksson U (1996) Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci, 93, 2576-2581.
66. Pardi G, Cetin I, Marconi AM, Bozzetti P, Buscaglia M, Makowski EL & Battaglia FC (1992) Venous drainage of the human uterus: respiratory gas studies in normal and fetal growth-retarded pregnancies. Am J Obstet Gynecol, 166, 699-706.
67. Pardi, G, Cetin I, Marconi AM, Lanfranchi A, Ferrazzi E, Bozzetti P, Buscaglia M & Battaglia FC (1993) Diagnostic value of blood sampling in fetuses with growth retardation. N Engl J Med, 328, 692-696.
68. Pollack RN & Divon MY (1992) Intrauterine growth retardation: Definition, classification and etiology. Clin Obstet Gynecol, 35, 99-107.
69. Rajakumar A & Conrad KP (2000) Expression, ontogeny and regulation of hypoxia-inducible transcription factors in the human placenta. Biol Reprod, 63, 559-569.
70. Rajakumar A, Whitelock KA, Weissfeld LA, Daftary AR, Markovic N & Conrad KP (2001) Selective overexpression of the hypoxia-inducible transcription factor, HIF-2a, in placentas from women with preeclampsia. Biol Reprod, 64, 499-506.
71. Redline RW & Patterson P (1995) Pre-eclampsia is associated with an excess of proliferative immature intermediate trophoblast. Human Pathol, 26, 594-600.
72. Regnault TRH, Orbus RJ, Battaglia FC, Wilkening RB & Anthony RV (1999) Altered arterial concentrations of placental hormones during maximal placental growth in a model of placental insufficiency. J Endocrinol, 162, 433-442.
73. Roberson WB, Brosens I & Dixon HG (1975) Uteroplacenta vascular pathology. Eur J Obstet Gynecol Reprod Biol, 5, 47-65.
74. Ross JC, Fennessey PV, Wilkening RB, Battaglia FC & Meschia G (1996) Placental transport and fetal utilization of leucine in a model of fetal growth retardation. Am J Physiol, 270, E491-E503.
75. Salafia CM, Pezzullo JC, Minior VK & Divon MY (1997) Placental pathology of absent and reversed end-diastolic flow in growth-restricted fetuses. Obstet Gynecol, 90, 830-836.
76. Schweiki D, Itin A, Neufeld G, Gitay-Goren H & Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia initiated angiogenesis. Nature, 359, 843-845.
77. Shams M & Ahmed A (1994) Localization of mRNA for basic fibroblast growth factor in human placenta. Growth Factors, 11, 105-111.
78. Sharkey AM, Charnock-Jones DS, Boocock CA, Brown KD & Smith SK (1993) Expression of mRNA for vascular endothelial growth factor in human placenta. J Reprod Fertil, 99, 609-615.
79. Shih SC & ClafFey KP (1999) Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogenous nuclear ribonucleoprotein L. J Biol Chem, 274, 1359-1365.
80. Shima DT, Deutsch U & D'Amore PA (1995) Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Letters, 370, 203-208.
81. Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR & Torry DS (1997) Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta, 18, 657-665.
82. Stavri G, Zachary I, Baskerville P, Martin J & Erusalimsky J (1995) Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation, 92, 5-8.
83. Stegeman JHJ (1974) Placental development in the sheep and its relation to fetal development. A qualitative and quantitative anatomic and histologic study. Bijdragen Tot De Dierkunde, 44, 3-72.
84. Steven D (1975) Anatomy of the placental barrier. In Comparative placentation. Essays in Structure and Function (Ed.) Steven DH, pp. 25-27. London: Academic Press.
85. Thomas KA (1996) Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem, 271, 603-606.
86. Thureen PJ, Trembler KA, Meschia G, Makowski EL & Wilkening RB (1992) Placental glucose transport in heat-induced fetal growth retardation. Am J Physiol, 263, R578-R585.
87. Tidwell SC, Ho HN, Chiu WH, Torry RJ & Torry DS (2001) Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol, 184, 1267-1272.
88. Torry DS, Wang HS, Wang TH, Caudle MR & Torry RJ (1998) Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol, 179, 1539-1544.
89. Trudinger BJ, Cook Cm, Giles WB, Connelly A & Thompson RS (1987) Umbilical artery velocity waveforms in high-risk pregnancy. Randomized controlled trial. Lancet, 1, 188-190.
90. Vuckovic M, Ponting J, Terman BI, Niketic V, Seif MW & Kumar S (1996) Expression of vascular endothelial growth factor receptor, KDR, in human placenta. J Anat, 188, 361-366.
91. Vuorela P, Hatva E, Lymboussaki A, Kaipainen A, Joukov V, Persico MG, Alitalo K & Halmesmaki E (1997) Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod, 56, 489-494.
92. 2 tension. Proc Natl Acad Sci, 92, 5510-5514.
93. Wheeler T, Elcock CL & Anthony FW (1995) Angiogenesis in the placental environment. Placenta, 16, 289-296.
94. Wooding FB (1992) Current topics: the synepitheliochorial placenta of ruminants: binucleate cell fusions and hormone production. Placenta, 13, 101-113.
95. Yamada Y, Nezu J, Shimane M & Hirata Y (1997) Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics, 42, 483-488.